Patents Assigned to Mobidiag Ltd.
  • Methods for Detecting the Presence of a Hypervirulent Clostridium Difficile Strain
    Publication number: 20230323478
    Abstract: The present invention provides a nucleic acid amplification based method for detecting a hypervirulent Clostridium difficile strain in a biological sample. The present invention is based on the use of oligonucleotide primers and probes specific to negative and positive markers in hypervirulent Clostridium difficile genome.
    Type: Application
    Filed: December 22, 2022
    Publication date: October 12, 2023
    Applicant: Mobidiag Ltd
    Inventors: Juha Kirveskari, Jaakko Kurkela
  • Method for detecting the presence of a hypervirulent strain
    Patent number: 11566294
    Abstract: The present invention provides a nucleic acid amplification based method for detecting a hypervirulent Clostridium difficile strain in a biological sample. The present invention is based on the use of oligonucleotide primers and probes specific to negative and positive markers in hypervirulent Clostridium difficile genome.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 31, 2023
    Assignee: Mobidiag Ltd.
    Inventors: Juha Kirveskari, Jaakko Kurkela